Table 1. Baseline clinical characteristics of the study population.
| Characteristics | All patients |
| Age, yrs | 54.7 ± 8.2 |
| Male | 128 (31.8%) |
| BMI, kg/m2 | 23.9 ± 3.4 |
| Hypertension | 100 (24.8%) |
| Coronary artery disease | 38 (9.4%) |
| Diabetes mellitus | 35 (8.7%) |
| History of AF | 35 (8.7%) |
| Congestive heart failure | 49 (12.2%) |
| Embolic events | 60 (14.9%) |
| Cerebral embolism | 53 (88.3%) |
| Lower limb arterial embolism | 6 (10%) |
| Pulmonary embolism | 1 (1.7%) |
| Myxoma location | |
| Left atrium | 374 (92.8%) |
| Right atrium | 29 (7.2%) |
| Myxoma dimension | |
| Dimension 1, mm | 40.3 ± 18.1 |
| Dimension 2, mm | 30.2 ± 12.1 |
| LAD, mm | 37.2 ± 6.4 |
| LVEDD, mm | 46.9 ± 5.4 |
| LVESD, mm | 30.3 ± 4.5 |
| LVEF | 64.4% ± 6.0% |
Data are presented as means ± SD or n (%). AF: atrial fibrillation; BMI: body mass index; LAD: left atrial diameter; LVEDD: left ventricular end-diastolic dimension; LVEF: left ventricular ejection fraction; LVESD: left ventricular end-systolic dimension.